AMGN

Amgen Inc

345.60

+7.38+2.18%

After Hours: 346.80 +1.20 +0.35%16:13 06/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE345.87/338.22

TODAY RANGE342.25-349.18

VOL2.90M

MARKET CAP186.52B

52 WEEK RANGE260.01-388.36

AVG VOL (3M)2.59M

% TURNOVER0.54%

TURNOVER--

P/E (TTM)24.03

% RANGE2.05%

EPS(TTM)14.38

P/E(FORWARD)22.04

P/B20.30

BVPS17.03

DIVIDEND10.08

P/S5.07

BETA--

DIV YIELD2.92%

FREE FLOAT MKT CAP186.08B

SHARES OUTSTANDING539.71M

NEXT EARNINGS08/03-08/07

FREE FLOAT538.41M

LOT SIZE1

EX-DATE05/15/2026

News

Press Releases

Financial Reports

Profile

PUBT·11m ago
Amgen to present at Goldman Sachs Global Healthcare Conference webcast
PR Newswire·12m ago
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
NASDAQ·5h ago
Vanguard Value ETF Experiences Big Inflow
Dow Jones·11h ago
Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors
Simply Wall St·14h ago
Assessing Amgen (AMGN) Valuation After Imdelltra Approval And Concerns Over Tavneos And Prolia
PUBT·22h ago
Amgen CEO Bradway says AI reshapes drug discovery and development
Benzinga·1d ago
Reported June 1, 2026: European Commission Approves Amgen's IMDYLLTRA For The Treatment Of Extensive-Stage Small Cell Lung Cancer
PUBT·1d ago
EU approves Amgen’s Imdylltra for advanced small-cell lung cancer
PR Newswire·1d ago
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
Dow Jones·1d ago
Sino Biopharmaceutical Stock Slips 2.3% in Hong Kong
Simply Wall St·1d ago
EU Approval Of IMDYLLTRA Puts Amgen’s Lung Cancer Ambitions In Focus
Seeking Alpha·2d ago
Amgen wins EU approval for Imdylltra in small cell lung cancer
Reuters·2d ago
Health Rounds: Radiation-emitting implant improves outcomes after brain cancer surgery
TipRanks·2d ago
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Thermo Fisher (TMO)
Dow Jones·2d ago
Sino Biopharmaceutical Stock Slides 1.4% in Hong Kong, Underperforms Competitors

Same Industry

Name/Symbol

Change%

Price

AMGN

McKesson

MCK

-1.92%

742.44

Biogen Inc

BIIB

-2.98%

186.51

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+0.26%

0.1153

SHPG

Celgene

CELG

0.00%

108.24

Lilly Eli & Co

LLY

-1.67%

Therapeuticsmd Inc

TXMD

+1.42%

2.140

Johnson & Johnson

JNJ

-2.37%

225.33

Abbvie Inc

ABBV

-2.20%

212.93

ZTS

Gilead Sciences Inc

GILD

-1.31%

134.43

NVO

BMY

ALXN

Pfizer

PFE

+1.48%

25.72

SNY

GCVRZ

Novartis

NVS

-0.81%

150.17

Dr Reddys Labs

RDY

-1.55%

13.06

GSK PLC

GSK

+1.16%

49.57

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.